MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

By A. Junker, M. Krumbholz, S. Eisele, Hema Mohan, Florian Augstein, R. Bittner, Hans Lassmann, H. Wekerle, R. Hohlfeld, E. Meinl. Brain : a journal of neurology, 2009

613 citations recorded by the source corpus.

Subfields: Cancer Research, Immunology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/0b7565e154f29b39374e966b346e31176bacd860

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. D. Rao
2. David Baltimore
3. Ryan M. O’Connell
4. Aadel A Chaudhuri
5. Yu Li
6. Kris V. Kowdley
7. David P. Bartel

In Immunology

1. Ryan M. O’Connell
2. D. Rao
3. David Baltimore
4. June L. Round

In Molecular Biology

1. David Baltimore
2. Ryan M. O’Connell
3. D. Rao
4. Aadel A Chaudhuri
5. Yu Li
6. Kris V. Kowdley
7. June L. Round
8. S. Mazmanian

Citations in the corpus

• MicroRNAs in Common Human Diseases (2012, background): “Immune-related diseases Multiple sclerosis miR-145, miR-34a, miR-155, miR-326 [80,81] Systemic lupus erythematosus miR-146a [82,83] Type II diabetes miR-144, miR-146a, miR-150, miR-182, miR-103, miR-107 [84] Nonalcoholic fatty liver disease miR-200a, miR-200b, miR-429, miR-122, miR-451, miR-27 [86] ”
• MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development (2010, background): “Elevated expression of miR-155 has been observed in brain lesions from multiple sclerosis (MS) patients (Junker et al., 2009) and in synovial samples from patients with rheumatoid arthritis (RA) (Stanczyk et al., 2008).”
• The blood-brain barrier in systemic inflammation. (2017, neutral): “Up-regulation of miR-155 in active MS lesions (Junker et al., 2009), with corresponding down-regulation of BBB tight junction components (Lopez-Ramirez et al., 2014), may be involved.”